REVBW

Revelation Biosciences, Inc. REVBW

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode REVBW VRPX SLXNW DRMA CDT AKTX PPBT XAGE ACON PBM
6M -18.47 % -95.22 % -23.37 % 432.80 % -96.12 % -32.62 % -74.81 % -89.14 % -5.72 % 0.72 %
YTD -7.25 % -99.88 % 54.18 % 198.56 % -99.54 % -33.17 % -86.28 % -97.21 % -93.29 % -76.06 %
1Y 6.67 % -99.90 % -29.64 % 221.71 % -99.66 % -68.29 % -84.79 % -94.41 % -94.34 % -93.80 %
3Y -68.08 % -100.00 % -77.24 % -97.52 % -100.00 % -91.75 % -98.39 % -99.80 % -99.99 % -99.91 %
5Y -95.08 % -100.00 % -77.24 % -99.67 % -100.00 % -97.74 % -99.25 % -99.80 % -100.00 % -99.91 %
10Y -95.08 % -100.00 % -77.24 % -99.67 % -100.00 % -99.78 % -99.90 % -99.80 % -100.00 % -99.91 %
From the beginning -95.08 % -100.00 % -77.24 % -99.67 % -100.00 % -99.75 % -99.90 % -99.80 % -100.00 % -99.91 %

Dividend